Last quarter (Q0 0), Spencer Pharmaceutical's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Spencer Pharmaceutical's net income was $-509.69K. See Spencer Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 03
Dec 02
Dec 01
Total Revenue
$ ―
$ ―
$ ―
Gross Profit
$ ―
$ ―
$ ―
Operating Expenses
$ ―
$ ―
$ ―
Depreciation and Amortization
$ ―
$ 10.07K
$ 4.55K
EBITDA
$ -862.54K
$ -2.23M
$ -1.01M
Operating Income
$ -862.54K
$ -2.28M
$ -2.24M
Other Income/Expenses
$ ―
$ ―
$ ―
Pretax Income
$ ―
$ ―
$ ―
Net Income
$ -862.54K
$ -2.24M
$ -2.23M
Per Share Metrics
Basic EPS
$ ―
$ ―
$ ―
Diluted EPS
$ ―
$ ―
$ ―
Weighted Average Shares Outstanding
―
―
―
Weighted Average Shares Outstanding (Diluted)
―
―
―
Currency in USD
Spencer Pharmaceutical Earnings and Revenue History